Arcus Biosciences, Inc. (RCUS) Income Annual - Discounting Cash Flows
RCUS
Arcus Biosciences, Inc.
RCUS (NYSE)
Period Ending: LTM
(Last Twelve Months)
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
Report Filing 2025-10-28 2025-02-25 2024-02-21 2023-02-28 2022-02-23 2021-02-25 2020-03-05 2019-03-05 2017-12-31 2016-12-31
Revenue 240 258 117 112 383 78 15 8.35 1.41 0
Cost of Revenue 4 10 0 0 0 0 0 0 0 1.31
Gross Profit 238 -190 117 112 383 78 15 8.35 1.41 -1.31
Operating Expenses 613 140 457 392 329 202 103.7 63.21 54.85 16.87
Research & Development 503 448 340 288 257 159 78.48 49.65 47.22 14.25
Selling, General and Administrative 112 120 117 104 72 43 25.23 13.57 7.64 3.94
Other Operating Expenses -2 -428 0 0 0 0 0 0 0 -1.31
Operating Income -375 -330 -340 -280 54 -124 -88.71 -54.86 -53.44 -18.18
Net Non-Operating Interest 25 48 39 14 1 1 5.2 4.92 0.775 0.212
Interest Income 33 52 41 16 1 1 5.2 4.92 0.775 0.212
Interest Expense 8 4 2 2 0 0 0 0 0 0
Equity & Other Income/(Expense) 1 -1 0 0 0 0 -1.2 0.343 -0.416 0
Income Before Tax -349 -283 -301 -266 55 -123 -84.71 -49.59 -53.08 -17.97
Income Tax Expense 1 1 6 1 2 0 0 0 0 0
Income Attributable to Non-Controlling Interest -1 -1 0 0 0 0 0 0 0 0
Net Income -349 -283 -307 -267 53 -123 -84.71 -49.59 -53.08 -17.97
Depreciation and Amortization 10 10 8 6 4 3 3.58 3.66 2.61 1.31
EBITDA -365 -320 -332 -274 58 -121 -85.13 -51.2 -50.83 -16.87
Earnings Per Share (EPS) -3.4 -3.14 -4.15 -3.71 0.76 -2.13 -1.73 -1.43 -2.16 -0.73
Diluted Earnings Per Share -3.4 -3.14 -4.15 -3.71 0.71 -2.13 -1.73 -1.43 -2.16 -0.73
Weighted Average Shares Outstanding 106.5 90.1 74 72 69.35 54.79 43.83 34.62 24.55 24.55
Diluted Weighted Average Shares Outstanding 106.5 90.1 74 72 73.97 54.79 43.83 34.62 24.55 24.55
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program